ST Pharm's Family
Beyond the Limits and Fly High
Walking Together with ST PHARM
Gene therapy CDMO from oligonucleotide to xRNA
Seamless development from manufacturing to non-clinical animal safety service
ST Pharm
ST Pharm
South Korea
- Seoul Office, Sihwa & Banwol Campus
- CDMO service (Small molecule, Oligonucleotide, mRNA))
- R&D (Vaccines, New drugs, etc.)
T+82 031 310 1100
Anapath Services (CRO)
Anapath Services
Basel, Switzerland
- Histopathology service
T+41 61 906 40 00 Einfo@anapath.ch
AnaPath Research (CRO)
AnaPath Research
Barcelona, Spain
- Non-clinical animal safety assessment
T+34 93 719 03 61 Einfo@anapathresearch.com
LEVATIO
LEVATIO
San Diego, USA
- Platform-based biotech
(mRNA, CAR-NKT, circ-RNA, etc.)
Eadmin@levatiotherapeutics.com
STP America Research
STP America Research
Delaware, USA
- USA Headquarters of ST Pharm
- A liaison office for connections between global R&D institutions and academies
VERNAGEN
VERNAGEN
Atlanta, USA
- mRNA Vaccines & Therapeutics-based biotech
ST Pharm's Facilities
Beyond the Limits and Fly High
Walking Together with ST PHARM
Sihwa Campus
R&D Center
QA / QC
Main Office
(Cafeteria, etc.)
Plant 6
Oligo Plant
(Pilot scale)
Banwol Campus
Oligo the 1st Plant
(Commercial scale)
Innovation Center
(R&D Center)
Main Office
(Cafeteria, etc.)
mRNA Plant
Synthetic Plant C
Synthetic Plant B
Synthetic Plant A
the 2nd Oligo Plant
General Capacity
Small Molecule
Kilo: 50 – 100
Pilot: 200 – 500
Kilo: 100
Sector 3/4: 500 – 2,000
Oligo Plants
above (4.6 mole scale):
in 2022
* Oligo Capacity : 3.5 x the current capacity, Global No.1 (6.4mol, in 2022)